골전이 진단 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The global bone metastatic diagnostics market size is expected to reach USD 41.81 Billion in 2034 from USD 20.28 Billion in 2025, growing at a CAGR of 8.37% during 2026-2034.This market is growing as healthcare providers increasingly focus on earlier identification and monitoring of bone metastases in cancer patients. Bone metastatic diagnostics support disease staging, treatment planning, and assessment of therapeutic response. Growing cancer incidence and improved awareness of metastatic complications are increasing demand for imaging and diagnostic technologies. Hospitals and oncology centers are adopting advanced diagnostic approaches that can provide more detailed information about skeletal involvement, supporting more informed clinical decisions and helping physicians manage patients with complex metastatic disease.

Growth is being driven by advances in medical imaging, increasing oncology screening, and improvements in diagnostic accuracy. Technologies such as PET, MRI, CT, bone scintigraphy, and molecular imaging are being used according to clinical requirements. The development of targeted imaging agents is also expanding diagnostic capabilities by enabling more specific identification of metastatic lesions. Increasing investment in cancer care infrastructure and multidisciplinary oncology services is further supporting adoption. Improvements in image processing and artificial intelligence may also enhance interpretation and help clinicians identify subtle abnormalities.

Future prospects remain favorable as oncology care becomes increasingly personalized and dependent on accurate disease characterization. Molecular imaging and hybrid imaging technologies could provide additional information about tumor biology and treatment response. Artificial intelligence may support automated image analysis, lesion detection, and diagnostic decision-making. Expanding cancer care infrastructure in emerging markets can create additional opportunities as access to advanced imaging improves. Providers that combine diagnostic accuracy, efficient workflows, interoperability, and cost-effective technologies will be positioned to benefit from the continuing evolution of metastatic cancer management.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

• Osteolytic Bone Metastasis
• Osteoblastic Bone Metastasis
• Mixed Bone Metastasis

By Diagnosis

• Biopsy
• Blood Test
• Imaging

By End User

• Hospitals
• Ambulatory Surgical Centers

COMPANIES PROFILED

• General Electric Company, Koninklijke Philips N.V., Siemens Healthcare GmbH, Carestream Health, FUJIFILM Corporation, Canon Medical Systems, Hitachi Ltd., Brainlab AG, Varian Medical Systems

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL BONE METASTATIC DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Osteolytic Bone Metastasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Osteoblastic Bone Metastasis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Mixed Bone Metastasis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BONE METASTATIC DIAGNOSTICS MARKET: BY DIAGNOSIS 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Diagnosis
• 5.2. Biopsy Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Blood Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BONE METASTATIC DIAGNOSTICS MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BONE METASTATIC DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Diagnosis
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Diagnosis
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Spain
  • 7.3.9 Russia
  • 7.3.10 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Diagnosis
  • 7.4.3 By End User
  • 7.4.4 China
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 India
  • 7.4.8 Australia
  • 7.4.9 South East Asia
  • 7.4.10 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Diagnosis
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Diagnosis
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BONE METASTATIC DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 General Electric Company
  • 9.2.2 Koninklijke Philips N.V
  • 9.2.3 Siemens Healthcare GmbH
  • 9.2.4 Carestream Health
  • 9.2.5 FUJIFILM Corporation
  • 9.2.6 Canon Medical Systems
  • 9.2.7 Hitachi Ltd
  • 9.2.8 Brainlab AG
  • 9.2.9 Varian Medical Systems